• According to co-developer Frédéric Leblond, PhD, Professor in Engineering Physics at Polytechnique Montréal, and co-senior author of the study, the probe technique uses Raman spectroscopy laser technology to measure light scattered from molecules, based on preliminary tests on patients with grade 2, 3 and 4 gliomas.
  • “The emitted light provides a spectroscopic signal that can be interpreted to provide specific information about the molecular makeup of the interrogated tissue,” says Leblond.
  • The Montreal Neurological Institute and Hospital plans to launch a trial for patients with newly diagnosed and recurrent glioblastoma.

Share This Article